Tenderwize
Back to tender search

Open-House contract for Bimatoprost/Timolol eye drops

Techniker Krankenkasse·Hamburg, Germany·Deadline Dec 29, 2026 · 133 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2024-14 - Bimatoprost / Timolol (Darreichungsform: Augentropfen als Einzeldosispipetten)

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

The notice says offers/contracts cannot be submitted through the procurement portal and must instead be sent by email w...

Participation is limited to pharmaceutical undertakings meeting AMG seat and authorisation requirements for the specifi...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Dec 2026
  • Conclusion of pharmaceutical rebate contracts under Section 130a(8) SGB V for Bimatoprost/Timolol eye drops in single-dose pipettes.
  • Open-House model with uniform terms; no individual contract negotiations.
Show full summary

This is a German Open-House pharmaceutical supply arrangement for Bimatoprost/Timolol eye drops in single-dose pipettes, led by Techniker Krankenkasse with HEK as a participating buyer. It is not a classic award procedure: no individual negotiations, no exclusivity, and contract entry is possible throughout the contract period if eligibility conditions are met. The notice and XML indicate electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post. No contract value is stated.

Risks

The notice says offers/contracts cannot be submitted through the procurement portal and must instead be sent by email w...

Participation is limited to pharmaceutical undertakings meeting AMG seat and authorisation requirements for the specifi...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Bidder must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal product(s).
  • Bidder must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Bidder must hold a valid marketing authorisation for the contract medicinal product(s) or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House contract for Bimatoprost/Timolol eye drops

Open-House pharmaceutical rebate contract for the fixed medicinal product combination Bimatoprost/Timolol in the form of single-dose eye drops. Scope is nationwide in Germany and the arrangement is open to all suitable pharmaceutical companies meeting the stated conditions. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Dec 2024 - Dec 2026

Category

Pharmaceutical products

Deadline

Deadline Dec 29, 2026

Procurement Details

Publication date
17 Nov 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
702294-2024

Documents (1)

Similar tenders